-
公开(公告)号:EP2291079A4
公开(公告)日:2011-06-22
申请号:EP09747191
申请日:2009-05-06
申请人: MERCK SHARP & DOHME
发明人: FAN HAIHONG , MAHJOUR MAJID , MOSER JUSTIN , REGE BHAGWANT
IPC分类号: A61K31/425
CPC分类号: A61K47/38 , A61K9/10 , A61K9/2018 , A61K9/2054 , A61K31/275 , A61K31/424 , A61K31/44 , A61K47/32 , Y10S514/96 , Y10S514/961
-
公开(公告)号:EP2026766A1
公开(公告)日:2009-02-25
申请号:EP07725455.5
申请日:2007-05-16
申请人: Synthon B.V.
CPC分类号: A61K9/2027 , A61K9/2054 , Y10S514/96 , Y10S514/961 , Y10S514/964
摘要: The invention relates to a controlled release pharmaceutical tablet comprising: a) 0.1 to 1 weight % of tamsulosin, preferably tamsulosin hydrochloride; b) 40-80 weight % of a water-swellable matrix-forming composition comprising (i) a pH- sensitive swellable hydrophilic polymer, which is a cross-linked polyacrylic acid polymer, and (ii) a pH-insensitive swellable hydrophilic polymer; and c) optionally a water insoluble binder.
-
公开(公告)号:EP1162973B1
公开(公告)日:2005-05-25
申请号:EP00909776.7
申请日:2000-03-21
CPC分类号: A61K9/145 , A61K9/146 , A61K9/1617 , A61K9/1652 , A61K9/2081 , A61K9/5042 , A61K9/5084 , A61K31/4709 , Y10S514/951 , Y10S514/952 , Y10S514/96 , Y10S514/961 , Y10S514/962 , Y10S514/963 , Y10S514/964
摘要: Provided is a cilostazol preparation which comprises incorporating a fine powder of cilostazol into a dispersing and/or solubilizing agent thereby to enhance the dispersibility and/or solubility. Further, provided is a process for improving absorbability of a slightly soluble drug such as cilostazol even at the lower portion of the digestive tract, wherein said drug is hard to be absorbed at the lower portion of the digestive tract when a conventional method is used. According to the present invention, cilostazol is absorbed enough even at the lower portion of the digestive tract to have an effect as thrombolytic drug, cerebral circulation improving drug or the like.
-
公开(公告)号:EP0831791B1
公开(公告)日:2004-10-27
申请号:EP96919237.6
申请日:1996-06-07
发明人: FRIEND, David, R. , WONG, David
CPC分类号: A61K31/573 , A61K9/205 , A61K9/2054 , A61K9/286 , A61K31/58 , A61K31/606 , Y10S514/96 , Y10S514/961
-
5.
公开(公告)号:EP0989848B1
公开(公告)日:2004-09-29
申请号:EP98921690.8
申请日:1998-06-08
IPC分类号: A61K9/28
CPC分类号: A61K31/663 , A61K9/2081 , A61K9/2866 , A61K31/138 , A61K31/375 , A61K31/401 , A61K31/49 , A61K31/522 , A61K31/65 , A61K31/675 , A61K31/7072 , Y10S514/821 , Y10S514/96 , Y10S514/961 , Y10S514/962 , Y10S514/963 , Y10S514/964
摘要: A novel oral dosage to be delivered to the stomach comprising a safe and effective amount of an active ingredient selected from the group consisting of emepronium bromidebromide, doxycycline, and other tetracyclines/antibiotics, iron preparations, quinidine, nonsteroidal anti-inflammatory drugs, alprenolol, ascorbic acid, captopril, theophylline, zidovoudine (AZT), bisphosphonates and mixtures thereof and pharmaceutically acceptable excipients, wherein said oral dosage form is a generally oval form and film coated to facilitate rapid esophageal transit and avoid irritation in the mouth, buccal cavity, pharynx, and esophagus.
-
公开(公告)号:EP1206246A1
公开(公告)日:2002-05-22
申请号:EP00955250.6
申请日:2000-08-02
申请人: Drugtech Corporation
IPC分类号: A61K9/20
CPC分类号: A61K9/0056 , A61K9/1623 , A61K9/1658 , A61K9/2081 , Y10S514/96 , Y10S514/961
摘要: The present invention relates to a rapidly disintegratable tablet for administration with or without the use of water. The tablet comprises at least one active substance and a mixture of excipients. The excipients provide desired characteristics and physical properties and when the tablet is sintered, excellent tablet binding characteristics are obtained. The tablet is intended for oral administration and dissolves in the presence of water. Also disclosed is a process for the preparation of a rapidly disintegratable tablet for administration with or without the use of water. The process comprising dissolving at least one carbohydrate and at least one structuring protein or polymer in a suitable solvent, wherein the solvent provides high porosity upon drying; spray-drying said dissolved mixture to obtain matrix or bead; dry blending at least one binding polymer, and at least one active drug with the matrix or bead to obtain a pretableting formulation or adding at least one active drug to the matrix or bead dissolved or dispersed components before spray-drying; compressing the formulation to obtain a tablet; and sintering the tablet for a sufficient time and temperature to allow the binding polymer to change status or melt and allow the polymer to resolidify as the temperature is reduced to ambient temperature.
-
公开(公告)号:EP1189639A1
公开(公告)日:2002-03-27
申请号:EP00941027.5
申请日:2000-06-09
发明人: VAN DIJK, Gerard, Johan , EISSENS, Anko, Cornelus , FRIJLINK, Henderik, Willem , OLIVIER, Aart, Pieter, Cornelis , BOLHUIS, Gerad, Klaas
IPC分类号: A61K47/36
CPC分类号: A61K47/36 , Y10S514/951 , Y10S514/961
摘要: The invention relates to a novel filler-binder for tablets, which shows a significantly reduced lubricant sensitivity when compared to prior art filler-binders. The invention further relates to a process of making said filler-binder and to the tablet obtainable by said process.
-
公开(公告)号:EP0651997B1
公开(公告)日:1998-10-28
申请号:EP92924919.1
申请日:1992-12-15
发明人: MASAKI, Katsuhiro , BAN, Kazutoshi
CPC分类号: A61K9/0056 , A61K9/2018 , A61K9/2095 , Y10S514/96 , Y10S514/961
摘要: A solid preparation soluble in the buccal cavity, which is composed of a sugar comprising lactose and/or manitol and 0.1-1.2 w/w%, based on the sugar, of agar and an active ingredient and has a density of 400-1,000 mg/ml and such a strength as to withstand the handling in the manufacture thereof. It has such a sufficient practical solubility in the buccal cavity that even the aged or children having difficulty in swallowing a solid preparation, such as a tablet, can take it. It has an exceedingly high strength as compared with conventional open matrix structures and hence can withstand satisfactorily carrying and PTP packaging.
-
公开(公告)号:EP0687464A2
公开(公告)日:1995-12-20
申请号:EP95109188.3
申请日:1995-06-14
发明人: Machoczek, Horst
CPC分类号: A61K9/0007 , Y10S514/96 , Y10S514/961
摘要: Es werden ein Verfahren zur Herstellung mechanisch stabiler, sich mit hoher Auflösegeschwindigkeit auszeichnender Brausetabletten und entsprechende Brausetabletten beschrieben. Die Brausetabletten bestehen aus mindestens einem Wirkstoff oder einer Wirkstoffkombination, mindestens einem Bindemittel, gegebenenfalls Trägerstoffen, wie Süßstoffen, Aromen, Farbstoffen, Duftstoffen, Weichmachern, Bleichmitteln, und Brausezusätzen. Bei der Herstellung werden der Wirkstoff oder die Wirkstoffkombination und gegebenenfalls die Trägerstoffe mit dem Bindemittel vermischt. Danach werden in einem klimatisierten Raum zu dieser Mischung die Brausezusätze zugegeben. Anschließend wird die mit den Brausezusätzen versetzte Mischung tablettiert. Als Bindemittel für die Brausetabletten wird Propylenglycol oder Glycerin verwendet.
摘要翻译: 有制造的机械稳定的方法,以高的溶解速率显着方向泡腾片和泡腾片适当说明。 泡腾片包含至少一种活性物质或活性物质组合,至少一种粘结剂,任选的赋形剂,如甜味剂,调味剂,染料,香料,软化剂,漂白剂,和冰冻果子露。 在将活性成分或活性成分组合,并在适当的制剂,赋形剂与粘合剂混合。 此后,在空调对象空间至该混合物中,所述泡腾添加剂加入。 然后与泡腾添加剂混合物压片混合。 至于用于泡腾片丙二醇或甘油的粘合剂。
-
公开(公告)号:EP0651997A4
公开(公告)日:1995-03-02
申请号:EP92924919
申请日:1992-12-15
发明人: MASAKI KATSUHIRO , BAN KAZUTOSHI
CPC分类号: A61K9/0056 , A61K9/2018 , A61K9/2095 , Y10S514/96 , Y10S514/961
摘要: A solid preparation soluble in the buccal cavity, which is composed of a sugar comprising lactose and/or manitol and 0.1-1.2 w/w%, based on the sugar, of agar and an active ingredient and has a density of 400-1,000 mg/ml and such a strength as to withstand the handling in the manufacture thereof. It has such a sufficient practical solubility in the buccal cavity that even the aged or children having difficulty in swallowing a solid preparation, such as a tablet, can take it. It has an exceedingly high strength as compared with conventional open matrix structures and hence can withstand satisfactorily carrying and PTP packaging.
-
-
-
-
-
-
-
-
-